Details of the Drug Reposition

General Information of This Drug (ID: DMN9W53)

Drug Name
Zofin   DMN9W53

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Chronic obstructive pulmonary disease DISQCIRF CA22 Phase 1/2 [1]
Knee osteoarthritis DISLSNBJ FA01 Phase 1/2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT05643729) A Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion (IV) of ZofinTM for the Treatment of Chronic Obstructive Pulmonary Disease (COPD). U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of Organicell